A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk

Genes Chromosomes and Cancer

Volumn 50, Issue 11, 2011, Pages 887-895

  Martín Guerrero, Idoia ^a   Enjuanes, Anna ^b   Richter, Julia ^c   Ammerpohl, Ole ^c   Colomer, Dolors ^b   Ardanaz, Maite ^d   Marco, Fernando ^e   Salas, Antonio ^f   Campo, Elias ^b   Siebert, Reiner ^c   García Orad, Africa ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF KIEL   (Germany)

^d HOSPITAL TXAGORRITXU   (Spain)

^e HOSPITAL DE BASURTO   (Spain)

^f UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HEPITYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SPAIN;

AGED; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; COMPUTER SIMULATION; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 80052687354     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20912     Document Type: Article

References (43)

1. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
2. Bell CG, Beck S. 2009. Advances in the identification and analysis of allele-specific expression. Genome Med 1: 56.
3. Bose S, Starczynski J, Chukwuma M, Baumforth K, Wei W, Morgan S, Byrd P, Ying J, Grundy R, Mann JR, Tao Q, Taylor AM, Murray PG, Stankovic T. 2007. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation. J Pathol 213: 329-336.
4. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A. 2001. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 98: 581-584.
5. Cheung HH, Lee TL, Rennert OM, Chan WY. 2009. DNA methylation of cancer genome. Birth Defects Res C Embryo Today 87: 335-350.
6. Cheung HH, Lee TL, Davis AJ, Taft DH, Rennert OM, Chan WY. 2010. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer. Br J Cancer 102: 419-427.
7. Chim CS, Liang R, Kwong YL. 2002. Hypermethylation of gene promoters in hematological neoplasia. Hemato Oncol 20: 167-176.
8. Chim CS, Wong KY, Loong F, Srivastava G. 2005. Absence of ATM hypermethylation in mantle cell and follicular lymphoma. Leukemia 19: 880-882.
9. Choudhury A, Elliott F, Iles MM, Churchman M, Bristow RG, Bishop DT, Kiltie AE. 2008. Analysis of variants in DNA damage signalling genes in bladder cancer. BMC Med Genet 9: 69.
10. Conde L, Vaquerizas JM, Ferrer-Costa C, de la Cruz X, Orozco M, Dopazo J. 2005. PupasView: A visual tool for selecting suitable SNPs, with putative pathological effect in genes, for genotyping purposes. Nucleic Acids Res 33: W501-W505.
11. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K, Jacob ST. 2008. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68: 5049-5058.
12. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, Döhner K, Bentz M, Lichter P. 2000. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910-1916.
13. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25: 115-121.
14. Einarsdóttir K, Humphreys K, Bonnard C, Li Y, Li Y, Chia KS, Liu ET, Hall P, Liu J, Wedrén S. 2007. Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk. Hum Mol Genet 16: 154-164.
15. Enjuanes A, Benavente Y, Bosch F, Martín-Guerrero I, Colomer D, Pérez-Alvarez S, Reina O, Ardanaz MT, Jares P, García-Orad A, Pujana MA, Montserrat E, de Sanjosé S, Campo E. 2008. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer Res 68: 10178-10186.
16. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
17. Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stella S, Guida G, Michel A, Crespo M, Laoutaris N, Montserrat E, Anagnostopoulos A, Dighiero G, Fassas A, Caligaris-Cappio F, Davi F. 2005. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: The lesson of the IGHV3-21 gene. Blood 105: 1678-1685.
18. Goldin LR, Pfeiffer RM, Li X, Hemminki K. 2004. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: Results from the Swedish Family-Cancer Database. Blood 104: 1850-1854.
19. Gumy-Pause F, Wacker P, Maillet P, Betts DR, Sappino AP. 2006. ATM promoter analysis in childhood lymphoid malignancies: A brief communication. Leuk Res 30: 335-337.
20. Jaffe ES, Harris NL, Stein H, Vardiman JW; World Health Organization Classification of Tumors. 2001. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press.
21. Kastan MB, Lim DS, Kim ST, Xu B, Canman C. 2000. Multiple signaling pathways involving ATM. Cold Spring Harb Symp Quant Biol 65: 521-526.
22. Kerkel K, Spadola A, Yuan E, Kosek J, Jiang L, Hod E, Li K, Murty VV, Schupf N, Vilain E, Morris M, Haghighi F, Tycko B. 2008. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet 40: 904-908.
23. Khanna KK, Lavin MF, Jackson SP, Mulhern TD. 2001. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ 8: 1052-1065.
24. Koren M, Kimmel G, Ben-Asher E, Gal I, Papa MZ, Beckmann JS, Lancet D, Shamir R, Friedman E. 2006. ATM haplotypes and breast cancer risk in Jewish high-risk women. Br J Cancer 94: 1537-1543.
25. Laayouni H, Calafell F, Bertranpetit J. 2010. A genome-wide survey does not show the genetic distinctiveness of Basques. Hum Genet 127: 455-458.
26. Lee PH, Shatkay H. 2008. F-SNP: Computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36: D820-D824.
27. Livak KJ, Schmittgenm TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-428.
28. Murrell A, Heeson S, Cooper WN, Douglas E, Apostolidou S, Moore GE, Maher ER, Reik W. 2004. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: Interaction between genotype and epigenotype. Hum Mol Genet 13: 247-255.
29. Raval A, Byrd JC, Plass C. 2006. Epigenetics in chronic lymphocytic leukemia. Semin Oncol 33: 157-166.
30. Roman-Gomez J, Jimenez-Velasco A, Barrios M, Prosper F, Heiniger A, Torres A, Agirre X. 2007. Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes. Leuk Lymph 48: 1269-1282.
31. Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS. 2006. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood 108: 638-644.
32. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA. 2006. Specific activation of microRNA-127 with downregulation of the protooncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443.
33. Schaffner C, Stilgenbauer S, Rappold GA, Döhner H, Lichter P. 1999. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 94: 748-753.
34. Schwindt H, Vater I, Kreuz M, Montesinos-Rongen M, Brunn A, Richter J, Gesk S, Ammerpohl O, Wiestler OD, Hasenclever D, Deckert M, Siebert R. 2009. Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma. Leukemia 23: 1875-1884.
35. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PA, Taylor AM. 1999. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353: 26-29.
36. Stephens M, Donnelly P. 2003. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73: 1162-1169.
37. Stevenson FK, Caligaris-Cappio F. 2004. Chronic lymphocytic leukemia: Revelations from the B-cell receptor. Blood 10: 4389-4395.
38. Tapper W, Hammond V, Gerty S, Ennis S, Simmonds P, Collins A, Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) Steering Group, Eccles D. 2008. The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer. Breast Cancer Res 10: R108.
39. Tong WG, Wierda WG, Lin E, Kuang SQ, Bekele BN, Estrov Z, Wei Y, Yang H, Keating MJ, Garcia-Manero G. 2010. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics 5: 499-508.
40. Walsh CP, Chaillet JR, Bestor TH. 1998. Transcription of IAP endogenousretroviruses is constrained by cytosine methylation. Nat Genet 20: 116-117.
41. Wingender E, Chen X, Fricke E, Geffers R, Hehl R, Liebich I, Krull M, Matys V, Michael H, Ohnhäuser R, Prüss M, Schacherer F, Thiele S, Urbach S. 2001. The TRANSFAC system on gene expression regulation. Nucleic Acids Res 29: 281-283.
42. Yang H, Spitz MR, Stewart DJ, Lu C, Gorlov IP, Wu X. 2007. ATM sequence variants associate with susceptibility to non-small cell lung cancer. Int J Cancer 121: 2254-2259.
43. Zilberman D, Gehring M, Tran RK, Ballinger T, Henikoff S. 2007. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat Genet 39: 61-69.